Introduction Pharma tenders have evolved; they’re not just about the lowest price anymore. Hospitals, governmen...
Introduction As pharmaceutical companies expand into multiple markets and face ever-growing complexities in their reg...
Introduction In 2026, API pricing for global buyers will no longer be based only on manufacturing costs. Factors such...
Introduction Latin America is continuously evolving and growing in the field of pharmaceuticals. Due to the increasin...
Introduction In the year 2026, global sourcing of active pharmaceutical ingredients (APIs) has transformed into a hig...
Executive Summary For the global B2B pharmaceutical ecosystem, the year 2025 is seen as critical for both COVID-relat...
The complexities of global pharmaceutical sourcing have never been greater. By 2026, buyers are likely to face an increa...
Quick intro Global pharma buyers generally source their generic APIs from India and China due to their vast productio...
Introduction The pharmaceutical industry in the CIS (Commonwealth of Independent States) and Eastern Europe is develo...
Stay updated on pharma trends and marketplace opportunities.